Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

5.63
+0.05000.90%
Volume:110.34K
Turnover:621.79K
Market Cap:120.10M
PE:-1.14
High:5.80
Open:5.56
Low:5.56
Close:5.58
Loading ...
May 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 04, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 02, 2020

Major Issues Report

Current report, item 5.07
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Feb 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 23, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 27, 2019

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 21, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 27, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 26, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01